| (HKD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.38B | 40.63% |
| Operating expense | — | — |
| Net income | 173.20M | 416.37% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 2315.HK returned +160.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +68.1% |
| 1 year | +160.7% |
| All-time high | $65.00 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 2315.HK would be worth today ›No. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has not paid a dividend in the past 12 months.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is part of the Healthcare sector.
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has a market cap of 27.52B HKD, based on the latest quote.
